A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lo Cicero, Alessandra ^a   Jaskowiak, Anne Laure ^a   Egesipe, Anne Laure ^a   Tournois, Johana ^a   Brinon, Benjamin ^a   Pitrez, Patricia R ^b   Ferreira, Lino ^b   De Sandre Giovannoli, Annachiara ^c,d   Levy, Nicolas ^c,d   Nissan, Xavier ^a  

^a I Stem   (France)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ISOTRETINOIN; LAMIN A; PRELAMIN A; RETINOIC ACID;

ANTAGONISTS AND INHIBITORS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHILD; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SCREENING; HUMAN; INDUCED PLURIPOTENT STEM CELL; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PREMATURE AGING; PROGERIA; TISSUE REGENERATION;

AGING, PREMATURE; ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CHILD; GENE EXPRESSION REGULATION; GUIDED TISSUE REGENERATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ISOTRETINOIN; LAMIN TYPE A; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PROGERIA; TRETINOIN;

EID: 84991716145     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34798     Document Type: Article

References (45)

1. Merideth, M. A. et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. The New England journal of medicine 358, 592-604, doi: 10.1056/NEJMoa0706898 (2008).
2. De Sandre-Giovannoli, A. et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 300, 2055, doi: 10.1126/science.1084125 (2003).
3. Eriksson, M. et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298, doi: 10.1038/nature01629 (2003).
4. Cau, P. et al. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective. Semin Cell Dev Biol, doi: 10.1016/j.semcdb.2014.03.021 (2014).
5. Gordon, L. B., Rothman, F. G., Lopez-Otin, C., Misteli, T. Progeria: a paradigm for translational medicine. Cell 156, 400-407, doi: 10.1016/j.cell.2013.12.028 (2014).
6. Scaffidi, P., Misteli, T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nature cell biology 10, 452-459, doi: 10.1038/ncb1708 (2008).
7. Blondel, S. et al. Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome. Stem cells translational medicine 3, 510-519, doi: 10.5966/sctm.2013-0168 (2014).
8. Xiong, Z. M., LaDana, C., Wu, D., Cao, K. An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells. Aging 5, 288-303 (2013).
9. Mateos, J. et al. Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem cell research 11, 1137-1148, doi: 10.1016/j.scr.2013.07.004 (2013).
10. Yang, S. H. et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proceedings of the National Academy of Sciences of the United States of America 102, 10291-10296, doi: 10.1073/pnas.0504641102 (2005).
11. Capell, B. C. et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences of the United States of America 102, 12879-12884, doi: 10.1073/pnas.0506001102 (2005).
12. Fong, L. G. et al. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311, 1621-1623, doi: 10.1126/science.1124875 (2006).
13. Toth, J. I. et al. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proceedings of the National Academy of Sciences of the United States of America 102, 12873-12878, doi: 10.1073/pnas.0505767102 (2005).
14. Varela, I. et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nature medicine 14, 767-772, doi: 10.1038/nm1786 (2008).
15. Osorio, F. G. et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Science translational medicine 3, 106ra107, doi: 10.1126/scitranslmed.3002847 (2011).
16. Pellegrini, C. et al. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype. Oncotarget (2015).
17. Cao, K. et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Science translational medicine 3, 89ra58, doi: 10.1126/scitranslmed.3002346 (2011).
18. Gabriel, D., Roedl, D., Gordon, L. B., Djabali, K. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts. Aging cell 14, 78-91, doi: 10.1111/acel.12300 (2015).
19. Kubben, N., Brimacombe, K. R., Donegan, M., Li, Z., Misteli, T. A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds. Methods doi: 10.1016/j.ymeth.2015.08.024 (2015).
20. Blondel, S. et al. Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation. Cell death & disease 7, e2105, doi: 10.1038/cddis.2015.374 (2016).
21. Nissan, X., Blondel, S., Peschanski, M. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria. Biochemical Society transactions 39, 1775-1779, doi: 10.1042/BST20110659 (2011).
22. Zhang, J. et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell stem cell 8, 31-45, doi: 10.1016/j.stem.2010.12.002 (2011).
23. Liu, G. H. et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225, doi: 10.1038/nature09879 (2011).
24. Nissan, X. et al. Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neuralspecific miR-9 microRNA. Cell reports 2, 1-9, doi: 10.1016/j.celrep.2012.05.015 (2012).
25. Lo Cicero, A., Nissan, X. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery. Ageing research reviews 24, 343-348, doi: 10.1016/j.arr.2015.10.002 (2015).
26. Swift, J. et al. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science 341, 1240104, doi: 10.1126/science.1240104 (2013).
27. Larrieu, D., Britton, S., Demir, M., Rodriguez, R., Jackson, S. P. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 344, 527-532, doi: 10.1126/science.1252651 (2014).
28. Leid, M., Kastner, P., Chambon, P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends in biochemical sciences 17, 427-433 (1992).
29. Cunningham, T. J., Duester, G. Mechanisms of retinoic acid signalling and its roles in organ and limb development. Nature reviews. Molecular cell biology 16, 110-123, doi: 10.1038/nrm3932 (2015).
30. Zhang, S. et al. All-trans retinoic acid modulates Wnt3A-induced osteogenic differentiation of mesenchymal stem cells via activating the PI3K/AKT/GSK3beta signalling pathway. Molecular and cellular endocrinology 422, 243-253, doi: 10.1016/j.mce.2015.12.018 (2016).
31. Nardella, M. et al. Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells. Oncotarget 6, 32821-32840, doi: 10.18632/oncotarget.5104 (2015).
32. Baldwin, H. E. et al. 40 years of topical tretinoin use in review. Journal of drugs in dermatology: JDD 12, 638-642 (2013).
33. Gibbs, S., Backendorf, C., Ponec, M. Regulation of keratinocyte proliferation and differentiation by all-trans-retinoic acid, 9-cisretinoic acid and 1,25-dihydroxy vitamin D3. Archives of dermatological research 288, 729-738 (1996).
34. Breitman, T. R., Selonick, S. E., Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proceedings of the National Academy of Sciences of the United States of America 77, 2936-2940 (1980).
35. Altucci, L. et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nature medicine 7, 680-686, doi: 10.1038/89050 (2001).
36. Schenk, T., Stengel, S., Zelent, A. Unlocking the potential of retinoic acid in anticancer therapy. British journal of cancer 111, 2039-2045, doi: 10.1038/bjc.2014.412 (2014).
37. Huang, M. E. et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567-572 (1988).
38. Chen, Z. X. et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78, 1413-1419 (1991).
39. Tallman, M. S. et al. All-trans-retinoic acid in acute promyelocytic leukemia. The New England journal of medicine 337, 1021-1028, doi: 10.1056/NEJM199710093371501 (1997).
40. Wang, Z. Y., Chen, Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111, 2505-2515, doi: 10.1182/blood-2007-07-102798 (2008).
41. Davies, B. S. et al. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria. Human molecular genetics 19, 2682-2694, doi: 10.1093/hmg/ddq158 (2010).
42. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872, doi: 10.1016/j.cell.2007.11.019 (2007).
43. Ferreira, L. S. et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circulation research 101, 286-294, doi: 10.1161/CIRCRESAHA.107.150201 (2007).
44. Vazao, H., das Neves, R. P., Graos, M., Ferreira, L. Towards the maturation and characterization of smooth muscle cells derived from human embryonic stem cells. PloS one 6, e17771, doi: 10.1371/journal.pone.0017771 (2011).
45. Rodriguez, S., Coppede, F., Sagelius, H., Eriksson, M. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur J Hum Genet 17, 928-937, doi: 10.1038/ejhg.2008.270 (2009).